Both in Pharmaceuticals
Collegium Pharmaceutical vs Sagimet Biosciences Inc. Series A
Over the past year COLL returned −33.9% and SGMT returned +16.4%; their daily moves had a correlation of 0.11.
COLL −33.9% SGMT +16.4%Growth of $1, one year, split-adjusted
| Metric | COLL | SGMT |
|---|---|---|
| Price | $23.80 | $9.92 |
| Market cap | $774.8M | $703.4M |
| Today | −0.96% | −4.89% |
| 1 month | +9.0% | +5.9% |
| 6 months | −30.7% | +30.4% |
| Year to date | −48.6% | +67.6% |
| 1 year | −31.6% | +19.1% |
| Revenue growth (YoY) | +6.3% | — |
| Gross margin | 86.7% | — |
| Net margin | −7.5% | — |
| P/E (TTM) | 16.2× | — |
| Price / sales | 1.0× | — |
| Net cash | -$962.1M | $240.1M |
| Dividend yield | — | — |
| Volatility (60d) | 38.6% | 73.9% |
| Short % of float | 18.2% | 21.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).